Details

Autor(en) / Beteiligte

• Shyam, Sangeetha
• Gómez-Martínez, Carlos
• Paz-Graniel, Indira
• Gaforio, José J
• Martínez-González, Miguel Ángel
• Corella, Dolores
• Fitó, Montserrat
• Martínez, J Alfredo
• Alonso-Gómez, Ángel M
• Wärnberg, Julia
• Vioque, Jesús
• Romaguera, Dora
• López-Miranda, José
• Estruch, Ramon
• Tinahones, Francisco J
• Santos-Lozano, José Manuel
• Serra-Majem, J Luís
• Bueno-Cavanillas, Aurora
• Tur, Josep A
• Martín Sánchez, Vicente
• Pintó, Xavier
• Ortiz Ramos, María
• Vidal, Josep
• Mar Alcarria, Maria
• Daimiel, Lidia
• Ros, Emilio
• Fernandez-Aranda, Fernando
• Nishi, Stephanie K
• García Regata, Oscar
• Toledo, Estefania
• Sorli, Jose V
• Castañer, Olga
• Garcia-Rios, Antonio
• Valls-Enguix, Rafael
• Perez-Farinos, Napoleon
• Zulet, M Angeles
• Rayó-Gago, Elena
• Casas, Rosa
• Rivera-Izquierdo, Mario
• Tojal-Sierra, Lucas
• Damas-Fuentes, Miguel
• Buil-Cosiales, Pilar
• Fernández-Carrion, Rebeca
• Goday, Albert
• Peña-Orihuela, Patricia J
• Compañ-Gabucio, Laura
• Diez-Espino, Javier
• Tello, Susanna
• González-Pinto, Ana
• de la O, Víctor
• Delgado-Rodríguez, Miguel
• Babio, Nancy
• Salas-Salvadó, Jordi

Titel

Coronavirus disease 2019 is associated with long-term depressive symptoms in Spanish older adults with overweight/obesity and metabolic syndrome

Ist Teil von

• Psychological medicine, 2024-02, Vol.54 (3), p.620-630

Ort / Verlag

England: Cambridge University Press

Erscheinungsjahr

2024

Quelle

Applied Social Sciences Index & Abstracts (ASSIA)

Beschreibungen/Notizen

• The coronavirus disease 2019 (COVID-19) has serious physiological and psychological consequences. The long-term (>12 weeks post-infection) impact of COVID-19 on mental health, specifically in older adults, is unclear. We longitudinally assessed the association of COVID-19 with depression symptomatology in community-dwelling older adults with metabolic syndrome within the framework of the PREDIMED-Plus cohort. Participants ( = 5486) aged 55-75 years were included in this longitudinal cohort. COVID-19 status (positive/negative) determined by tests (e.g. polymerase chain reaction severe acute respiratory syndrome coronavirus 2, IgG) was confirmed via event adjudication (410 cases). Pre- and post-COVID-19 depressive symptomatology was ascertained from annual assessments conducted using a validated 21-item Spanish Beck Depression Inventory-II (BDI-II). Multivariable linear and logistic regression models assessed the association between COVID-19 and depression symptomatology. COVID-19 in older adults was associated with higher post-COVID-19 BDI-II scores measured at a median (interquartile range) of 29 (15-40) weeks post-infection [fully adjusted = 0.65 points, 95% confidence interval (CI) 0.15-1.15; = 0.011]. This association was particularly prominent in women ( = 1.38 points, 95% CI 0.44-2.33, = 0.004). COVID-19 was associated with 62% increased odds of elevated depression risk (BDI-II ≥ 14) post-COVID-19 when adjusted for confounders (odds ratio; 95% CI 1.13-2.30, = 0.008). COVID-19 was associated with long-term depression risk in older adults with overweight/obesity and metabolic syndrome, particularly in women. Thus, long-term evaluations of the impact of COVID-19 on mental health and preventive public health initiatives are warranted in older adults.